Loading…
Glycan Determinants of Heparin-Tau Interaction
Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer’s disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little...
Saved in:
Published in: | Biophysical journal 2017-03, Vol.112 (5), p.921-932 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43 |
---|---|
cites | cdi_FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43 |
container_end_page | 932 |
container_issue | 5 |
container_start_page | 921 |
container_title | Biophysical journal |
container_volume | 112 |
creator | Zhao, Jing Huvent, Isabelle Lippens, Guy Eliezer, David Zhang, Anqiang Li, Quanhong Tessier, Peter Linhardt, Robert J. Zhang, Fuming Wang, Chunyu |
description | Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer’s disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little is known about the glycan determinants of this interaction. Here, we used surface plasmon resonance (SPR) and NMR spectroscopy to characterize the interaction between two tau fragments, K18 and K19, and several polysaccharides, including heparin, heparin oligosaccharides, chemically modified heparin, and related glycans. Using a heparin-immobilized chip, SPR revealed that tau K18 and K19 bind heparin with a KD of 0.2 and 70 μM, respectively. In SPR competition experiments, N-desulfation and 2-O-desulfation had no effect on heparin binding to K18, whereas 6-O-desulfation severely reduced binding, suggesting a critical role for 6-O-sulfation in the tau-heparin interaction. The tau-heparin interaction became stronger with longer-chain heparin oligosaccharides. As expected for an electrostatics-driven interaction, a moderate amount of salt (0.3 M NaCl) abolished binding. NMR showed the largest chemical-shift perturbation (CSP) in R2 in tau K18, which was absent in K19, revealing differential binding sites in K18 and K19 to heparin. Dermatan sulfate binding produced minimal CSP, whereas dermatan disulfate, with the additional 6-O-sulfo group, induced much larger CSP. 2-O-desulfated heparin induced much larger CSP in K18 than 6-O-desulfated heparin. Our data demonstrate a crucial role for the 6-O-sulfo group in the tau-heparin interaction, which to our knowledge has not been reported before. |
doi_str_mv | 10.1016/j.bpj.2017.01.024 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5355497</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006349517301455</els_id><sourcerecordid>1878179916</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43</originalsourceid><addsrcrecordid>eNp9kV9rFDEUxYModq1-AF9kwRd9mDE3kz8TBKFU7RYWfKnPIZPcsRlmM2sys9Bvb9atRfvgUyD3d09OziHkNdAaKMgPQ93th5pRUDWFmjL-hKxAcFZR2sqnZEUplVXDtTgjL3IeKAUmKDwnZ6xlWkkBK1JfjXfOxvVnnDHtQrRxzuupX29wb1OI1Y1d1texzKybwxRfkme9HTO-uj_PyfevX24uN9X229X15cW2cgKaueLS8V5S7RW3XLYdtZ4zz5RooeW9ZRIt8-iUbi2FpnPCogDpOUfGoPO8OSefTrr7pduhdxjnZEezT2Fn052ZbDD_TmK4NT-mgxGNEFyrIvD-JHD7aG1zsTXHu5JfyUOoAxT23f1jafq5YJ7NLmSH42gjTks20KoWlNYgC_r2ETpMS4olit-UElrLo3s4US5NOSfsHxwANcfmzGBKc-bYXDFiSnNl583fP37Y-FNVAT6eACy5HwImk13A6NCHhG42fgr_kf8FTQenIQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1878759964</pqid></control><display><type>article</type><title>Glycan Determinants of Heparin-Tau Interaction</title><source>Open Access: PubMed Central</source><creator>Zhao, Jing ; Huvent, Isabelle ; Lippens, Guy ; Eliezer, David ; Zhang, Anqiang ; Li, Quanhong ; Tessier, Peter ; Linhardt, Robert J. ; Zhang, Fuming ; Wang, Chunyu</creator><creatorcontrib>Zhao, Jing ; Huvent, Isabelle ; Lippens, Guy ; Eliezer, David ; Zhang, Anqiang ; Li, Quanhong ; Tessier, Peter ; Linhardt, Robert J. ; Zhang, Fuming ; Wang, Chunyu</creatorcontrib><description>Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer’s disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little is known about the glycan determinants of this interaction. Here, we used surface plasmon resonance (SPR) and NMR spectroscopy to characterize the interaction between two tau fragments, K18 and K19, and several polysaccharides, including heparin, heparin oligosaccharides, chemically modified heparin, and related glycans. Using a heparin-immobilized chip, SPR revealed that tau K18 and K19 bind heparin with a KD of 0.2 and 70 μM, respectively. In SPR competition experiments, N-desulfation and 2-O-desulfation had no effect on heparin binding to K18, whereas 6-O-desulfation severely reduced binding, suggesting a critical role for 6-O-sulfation in the tau-heparin interaction. The tau-heparin interaction became stronger with longer-chain heparin oligosaccharides. As expected for an electrostatics-driven interaction, a moderate amount of salt (0.3 M NaCl) abolished binding. NMR showed the largest chemical-shift perturbation (CSP) in R2 in tau K18, which was absent in K19, revealing differential binding sites in K18 and K19 to heparin. Dermatan sulfate binding produced minimal CSP, whereas dermatan disulfate, with the additional 6-O-sulfo group, induced much larger CSP. 2-O-desulfated heparin induced much larger CSP in K18 than 6-O-desulfated heparin. Our data demonstrate a crucial role for the 6-O-sulfo group in the tau-heparin interaction, which to our knowledge has not been reported before.</description><identifier>ISSN: 0006-3495</identifier><identifier>EISSN: 1542-0086</identifier><identifier>DOI: 10.1016/j.bpj.2017.01.024</identifier><identifier>PMID: 28297651</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alzheimer's disease ; Biophysics ; Chemical and Process Engineering ; Dose-Response Relationship, Drug ; Engineering Sciences ; Heparin - chemistry ; Heparin - metabolism ; Human health and pathology ; Life Sciences ; Models, Molecular ; Neurons ; Peptide Fragments - chemistry ; Peptide Fragments - metabolism ; Prescription drugs ; Protein Binding - drug effects ; Protein Conformation ; Proteins ; Sodium Chloride - pharmacology ; Spectrum analysis ; Surface Plasmon Resonance ; tau Proteins - chemistry ; tau Proteins - metabolism</subject><ispartof>Biophysical journal, 2017-03, Vol.112 (5), p.921-932</ispartof><rights>2017 Biophysical Society</rights><rights>Copyright © 2017 Biophysical Society. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Biophysical Society Mar 14, 2017</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2017 Biophysical Society. 2017 Biophysical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43</citedby><cites>FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43</cites><orcidid>0000-0002-8236-0901</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355497/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355497/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28297651$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01600157$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Jing</creatorcontrib><creatorcontrib>Huvent, Isabelle</creatorcontrib><creatorcontrib>Lippens, Guy</creatorcontrib><creatorcontrib>Eliezer, David</creatorcontrib><creatorcontrib>Zhang, Anqiang</creatorcontrib><creatorcontrib>Li, Quanhong</creatorcontrib><creatorcontrib>Tessier, Peter</creatorcontrib><creatorcontrib>Linhardt, Robert J.</creatorcontrib><creatorcontrib>Zhang, Fuming</creatorcontrib><creatorcontrib>Wang, Chunyu</creatorcontrib><title>Glycan Determinants of Heparin-Tau Interaction</title><title>Biophysical journal</title><addtitle>Biophys J</addtitle><description>Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer’s disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little is known about the glycan determinants of this interaction. Here, we used surface plasmon resonance (SPR) and NMR spectroscopy to characterize the interaction between two tau fragments, K18 and K19, and several polysaccharides, including heparin, heparin oligosaccharides, chemically modified heparin, and related glycans. Using a heparin-immobilized chip, SPR revealed that tau K18 and K19 bind heparin with a KD of 0.2 and 70 μM, respectively. In SPR competition experiments, N-desulfation and 2-O-desulfation had no effect on heparin binding to K18, whereas 6-O-desulfation severely reduced binding, suggesting a critical role for 6-O-sulfation in the tau-heparin interaction. The tau-heparin interaction became stronger with longer-chain heparin oligosaccharides. As expected for an electrostatics-driven interaction, a moderate amount of salt (0.3 M NaCl) abolished binding. NMR showed the largest chemical-shift perturbation (CSP) in R2 in tau K18, which was absent in K19, revealing differential binding sites in K18 and K19 to heparin. Dermatan sulfate binding produced minimal CSP, whereas dermatan disulfate, with the additional 6-O-sulfo group, induced much larger CSP. 2-O-desulfated heparin induced much larger CSP in K18 than 6-O-desulfated heparin. Our data demonstrate a crucial role for the 6-O-sulfo group in the tau-heparin interaction, which to our knowledge has not been reported before.</description><subject>Alzheimer's disease</subject><subject>Biophysics</subject><subject>Chemical and Process Engineering</subject><subject>Dose-Response Relationship, Drug</subject><subject>Engineering Sciences</subject><subject>Heparin - chemistry</subject><subject>Heparin - metabolism</subject><subject>Human health and pathology</subject><subject>Life Sciences</subject><subject>Models, Molecular</subject><subject>Neurons</subject><subject>Peptide Fragments - chemistry</subject><subject>Peptide Fragments - metabolism</subject><subject>Prescription drugs</subject><subject>Protein Binding - drug effects</subject><subject>Protein Conformation</subject><subject>Proteins</subject><subject>Sodium Chloride - pharmacology</subject><subject>Spectrum analysis</subject><subject>Surface Plasmon Resonance</subject><subject>tau Proteins - chemistry</subject><subject>tau Proteins - metabolism</subject><issn>0006-3495</issn><issn>1542-0086</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kV9rFDEUxYModq1-AF9kwRd9mDE3kz8TBKFU7RYWfKnPIZPcsRlmM2sys9Bvb9atRfvgUyD3d09OziHkNdAaKMgPQ93th5pRUDWFmjL-hKxAcFZR2sqnZEUplVXDtTgjL3IeKAUmKDwnZ6xlWkkBK1JfjXfOxvVnnDHtQrRxzuupX29wb1OI1Y1d1texzKybwxRfkme9HTO-uj_PyfevX24uN9X229X15cW2cgKaueLS8V5S7RW3XLYdtZ4zz5RooeW9ZRIt8-iUbi2FpnPCogDpOUfGoPO8OSefTrr7pduhdxjnZEezT2Fn052ZbDD_TmK4NT-mgxGNEFyrIvD-JHD7aG1zsTXHu5JfyUOoAxT23f1jafq5YJ7NLmSH42gjTks20KoWlNYgC_r2ETpMS4olit-UElrLo3s4US5NOSfsHxwANcfmzGBKc-bYXDFiSnNl583fP37Y-FNVAT6eACy5HwImk13A6NCHhG42fgr_kf8FTQenIQ</recordid><startdate>20170314</startdate><enddate>20170314</enddate><creator>Zhao, Jing</creator><creator>Huvent, Isabelle</creator><creator>Lippens, Guy</creator><creator>Eliezer, David</creator><creator>Zhang, Anqiang</creator><creator>Li, Quanhong</creator><creator>Tessier, Peter</creator><creator>Linhardt, Robert J.</creator><creator>Zhang, Fuming</creator><creator>Wang, Chunyu</creator><general>Elsevier Inc</general><general>Biophysical Society</general><general>The Biophysical Society</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8236-0901</orcidid></search><sort><creationdate>20170314</creationdate><title>Glycan Determinants of Heparin-Tau Interaction</title><author>Zhao, Jing ; Huvent, Isabelle ; Lippens, Guy ; Eliezer, David ; Zhang, Anqiang ; Li, Quanhong ; Tessier, Peter ; Linhardt, Robert J. ; Zhang, Fuming ; Wang, Chunyu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Alzheimer's disease</topic><topic>Biophysics</topic><topic>Chemical and Process Engineering</topic><topic>Dose-Response Relationship, Drug</topic><topic>Engineering Sciences</topic><topic>Heparin - chemistry</topic><topic>Heparin - metabolism</topic><topic>Human health and pathology</topic><topic>Life Sciences</topic><topic>Models, Molecular</topic><topic>Neurons</topic><topic>Peptide Fragments - chemistry</topic><topic>Peptide Fragments - metabolism</topic><topic>Prescription drugs</topic><topic>Protein Binding - drug effects</topic><topic>Protein Conformation</topic><topic>Proteins</topic><topic>Sodium Chloride - pharmacology</topic><topic>Spectrum analysis</topic><topic>Surface Plasmon Resonance</topic><topic>tau Proteins - chemistry</topic><topic>tau Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Jing</creatorcontrib><creatorcontrib>Huvent, Isabelle</creatorcontrib><creatorcontrib>Lippens, Guy</creatorcontrib><creatorcontrib>Eliezer, David</creatorcontrib><creatorcontrib>Zhang, Anqiang</creatorcontrib><creatorcontrib>Li, Quanhong</creatorcontrib><creatorcontrib>Tessier, Peter</creatorcontrib><creatorcontrib>Linhardt, Robert J.</creatorcontrib><creatorcontrib>Zhang, Fuming</creatorcontrib><creatorcontrib>Wang, Chunyu</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biophysical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Jing</au><au>Huvent, Isabelle</au><au>Lippens, Guy</au><au>Eliezer, David</au><au>Zhang, Anqiang</au><au>Li, Quanhong</au><au>Tessier, Peter</au><au>Linhardt, Robert J.</au><au>Zhang, Fuming</au><au>Wang, Chunyu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycan Determinants of Heparin-Tau Interaction</atitle><jtitle>Biophysical journal</jtitle><addtitle>Biophys J</addtitle><date>2017-03-14</date><risdate>2017</risdate><volume>112</volume><issue>5</issue><spage>921</spage><epage>932</epage><pages>921-932</pages><issn>0006-3495</issn><eissn>1542-0086</eissn><abstract>Tau aggregates into paired helical filaments within neurons, a pathological hallmark of Alzheimer’s disease. Heparin promotes tau aggregation and recently has been shown to be involved in the cellular uptake of tau aggregates. Although the tau-heparin interaction has been extensively studied, little is known about the glycan determinants of this interaction. Here, we used surface plasmon resonance (SPR) and NMR spectroscopy to characterize the interaction between two tau fragments, K18 and K19, and several polysaccharides, including heparin, heparin oligosaccharides, chemically modified heparin, and related glycans. Using a heparin-immobilized chip, SPR revealed that tau K18 and K19 bind heparin with a KD of 0.2 and 70 μM, respectively. In SPR competition experiments, N-desulfation and 2-O-desulfation had no effect on heparin binding to K18, whereas 6-O-desulfation severely reduced binding, suggesting a critical role for 6-O-sulfation in the tau-heparin interaction. The tau-heparin interaction became stronger with longer-chain heparin oligosaccharides. As expected for an electrostatics-driven interaction, a moderate amount of salt (0.3 M NaCl) abolished binding. NMR showed the largest chemical-shift perturbation (CSP) in R2 in tau K18, which was absent in K19, revealing differential binding sites in K18 and K19 to heparin. Dermatan sulfate binding produced minimal CSP, whereas dermatan disulfate, with the additional 6-O-sulfo group, induced much larger CSP. 2-O-desulfated heparin induced much larger CSP in K18 than 6-O-desulfated heparin. Our data demonstrate a crucial role for the 6-O-sulfo group in the tau-heparin interaction, which to our knowledge has not been reported before.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28297651</pmid><doi>10.1016/j.bpj.2017.01.024</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-8236-0901</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-3495 |
ispartof | Biophysical journal, 2017-03, Vol.112 (5), p.921-932 |
issn | 0006-3495 1542-0086 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5355497 |
source | Open Access: PubMed Central |
subjects | Alzheimer's disease Biophysics Chemical and Process Engineering Dose-Response Relationship, Drug Engineering Sciences Heparin - chemistry Heparin - metabolism Human health and pathology Life Sciences Models, Molecular Neurons Peptide Fragments - chemistry Peptide Fragments - metabolism Prescription drugs Protein Binding - drug effects Protein Conformation Proteins Sodium Chloride - pharmacology Spectrum analysis Surface Plasmon Resonance tau Proteins - chemistry tau Proteins - metabolism |
title | Glycan Determinants of Heparin-Tau Interaction |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A18%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycan%20Determinants%20of%20Heparin-Tau%20Interaction&rft.jtitle=Biophysical%20journal&rft.au=Zhao,%20Jing&rft.date=2017-03-14&rft.volume=112&rft.issue=5&rft.spage=921&rft.epage=932&rft.pages=921-932&rft.issn=0006-3495&rft.eissn=1542-0086&rft_id=info:doi/10.1016/j.bpj.2017.01.024&rft_dat=%3Cproquest_pubme%3E1878179916%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c513t-46c4f609d74a468b0ad42d2758184fa26ea2dec798a013bc5ae516d44e221bd43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1878759964&rft_id=info:pmid/28297651&rfr_iscdi=true |